Drug interactions and the evolution of antibiotic resistance
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Large-scale, systems biology approaches now allow us to systematically map synergistic and antagonistic interactions between drugs. Consequently, drug antagonism is emerging as a powerful tool to study biological function and relatedness between cellular components as well as to uncover mechanisms of drug action. Furthermore, theoretical models and new experiments suggest that antagonistic interactions between antibiotics can counteract the evolution of drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the interactions can be highly dosedependent”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419
Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants
Tong, A. H. Y., Evangelista, M., Parsons, A. B., Xu, H., Bader, G. D., Pagé, N., Robinson, M., Raghibizadeh, S., Hogue, C. W. V., Bussey, H., et al. (2001) · Science · doi:10.1126/science.1065810 · Cited by 2,138
Global Mapping of the Yeast Genetic Interaction Network
Tong, A. H. Y., Lesage, G., Bader, G. D., Ding, H., Xu, H., Xin, X., Young, J., Berriz, G. F., Brost, R. L., Chang, M., et al. (2004) · Science · doi:10.1126/science.1091317 · Cited by 2,095
The search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
Schuldiner, M., Collins, S. R., Thompson, N. J., Denic, V., Bhamidipati, A., Punna, T., Ihmels, J., Andrews, B., Boone, C., Greenblatt, J. F., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.031 · Cited by 870
Collins, S. R., Miller, K. M., Maas, N. L., Roguev, A., Fillingham, J., Chu, C. S., Schuldiner, M., Gebbia, M., Recht, J., Shales, M., et al. (2007) · Nature · doi:10.1038/nature05649 · Cited by 869
Modular epistasis in yeast metabolism
Segrè, D., DeLuna, A., Church, G. M., & Kishony, R. (2005) · Nature Genetics · doi:10.1038/ng1489 · Cited by 575
Self-citationEpistasis and the Evolutionary Process
Hurst, L. D. (2000) · Heredity · doi:10.1046/j.1365-2540.2000.0846b.x · Cited by 563
A DNA Integrity Network in the Yeast Saccharomyces cerevisiae
Pan, X., Ye, P., Yuan, D. S., Wang, X., Bader, J. S., & Boeke, J. D. (2006) · Cell · doi:10.1016/j.cell.2005.12.036 · Cited by 537 · cited 1×
“Systematic screens for synergy between double gene knockouts have been successfully used to understand biological systems in bacteria and yeas”
Cited by
Items 201–300 of 340
Katsnelson, B. A. (2011) · The Open Epidemiology Journal · doi:10.2174/1874297101104010060 · Cited by 14
Campbell, E. M., & Chao, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086971 · Cited by 18
“Experimental evidence suggests that synergistic drug pairings may increase the strength and rate at which single and multiple drug resistance evolves under treatment [34–36].”
BackgroundProbing antimicrobial synergy by novel lipopeptides paired with antibiotics
Liao, M., Gong, H., Ge, T., Shen, K., Campana, M., McBain, A. J., Wu, C., Hu, X., & Lu, J. R. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.11.169 · Cited by 15
Lim, D., Thompson, H. M., Walz, C. R., Ayinala, S., Skinner, D. F., Zhang, S., Grayson, J. W., Cho, D., & Woodworth, B. A. (2020) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22656 · Cited by 13
Simwela, N. V., Hughes, K. R., Rennie, M. T., Barrett, M. P., & Waters, A. P. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00580 · Cited by 13
Kulik, E. M., Lenkeit, K., Waltimo, T. M. T., Weiger, R., & Walter, C. (2014) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2014.03.007 · Cited by 13
Weakest-Link Dynamics Predict Apparent Antibiotic Interactions in a Model Cross-Feeding Community
Adamowicz, E. M., & Harcombe, W. R. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00465-20 · Cited by 13
“Some research suggests that antibiotics which synergize in the short term may actually facilitate the evolution of resistance, while antagonistic interactions suppress resistance evolution (5, 59, 60).”
Coetzee, J. F., Cernicchiaro, N., Sidhu, P. K., & Kleinhenz, M. D. (2020) · Journal of Animal Science · doi:10.1093/jas/skaa109 · Cited by 12
Combinatorial Antimicrobial Susceptibility Testing Enabled by Non-Contact Printing
Opalski, A. S., Ruszczak, A., Promovych, Y., Horka, M., Derzsi, L., & Garstecki, P. (2020) · Micromachines · doi:10.3390/mi11020142 · Cited by 12
Çetin, E., Atılgan, A. R., & Atılgan, C. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00507 · Cited by 12
Fitness landscapes emerging from pharmacodynamic functions in the evolution of multidrug resistance
Engelstädter, J. (2014) · Journal of Evolutionary Biology · doi:10.1111/jeb.12355 · Cited by 12
Sardana, K., Khurana, A., & Singh, A. P. (2019) · Journal of Dermatological Treatment · doi:10.1080/09546634.2019.1675857 · Cited by 13
Yu, W., Guo, X., Li, X., Wei, Y., Lyu, Y., Zhang, L., Wang, J., & Shan, A. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101183 · Cited by 17
“Consequently, there exists an imperative need to formulate effective antibacterial agents [5 – 8].”
BackgroundLiao, M., Shen, K., Ma, K., Chen, Y., Li, P., Gutfreund, P., Hu, X., Petkov, J. T., & Lu, J. R. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.137891 · Cited by 11
Radi, M. S., Munro, L. J., Salcedo-Sora, J. E., Kim, S. H., Feist, A. M., & Kell, D. B. (2022) · Membranes · doi:10.3390/membranes12121264 · Cited by 11
Biochemical reaction network topology defines dose-dependent Drug–Drug interactions
Babaei, M., Evers, T. M. J., Shokri, F., Altucci, L., de Lange, E. C. M., & Mashaghi, A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106584 · Cited by 11
Feng, S., Wu, Z., Liang, W., Zhang, X., Cai, X., Li, J., Liang, L., Lin, D., Stoesser, N. E., Doi, Y., et al. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac086 · Cited by 12
“The prediction of AMR evolution, particularly among horizontally transferred genes, may contribute to the strategic design of appropriate treatments (Raymond et al. 2002; Yeh et al. 2009; Lee et al. 2013; Munck et al. 2014).”
Ohno, A., Kataoka, S., Ishii, Y., Terasaki, T., Kiso, M., Okubo, M., Yamaguchi, K., & Tateda, K. (2012) · Microbes and Environments · doi:10.1264/jsme2.me12137 · Cited by 15
“(24) mentioned that the choice between synergy and antagonism may involve a trade-off between immediate efficacy of inhibition of microbial growth and future forestallment of the evolution of resistance.”
BackgroundTesting the optimality properties of a dual antibiotic treatment in a two-locus, two-allele model
Peña‐Miller, R., Fuentes-Hernández, A., Reding, C., Gudelj, I., & Beardmore, R. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.1035 · Cited by 13
“It has also been shown that synergistic combinations can accelerate the evolution of antibiotic resistance [25] and, as a result, it was suggested that ‘antagonistic’ drug interactions, seemingly neglected in clinical practice, might slow resistance evolution [26].”
BackgroundMinimal biophysical model of combined antibiotic action
Kavčič, B., Tkačik, G., & Bollenbach, T. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008529 · Cited by 16
“Due to the looming antibiotic-resistance crisis [2], understanding and predicting bacterial responses to antibiotics is becoming increasingly important.”
Karlsson, H., Senkowski, W., Fryknäs, M., Mansoori, S., Linder, S. T., Gullbo, J., Larsson, R. L., & Nygren, P. (2019) · Oncotarget · doi:10.18632/oncotarget.27166 · Cited by 10
“In this study, the interaction between drug and radiation was analyzed in accordance with independent Bliss interaction, which assumes that the effect of a treatment is independent of the presence of the other treatment [22].”
MethodMaqbool, T., Hadi, F., Razzaq, S., Naz, S., Aftab, S., Khurshid, S., Awan, S. J., Nawaz, A., Abid, F., & Malik, A. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.3.843 · Cited by 10
“However, when combined, the drugs interact in many unexpected ways they show a variety of different results (Yeh et al., 2009).”
BackgroundGemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid cancer
Sandblom, V., Spetz, J. K. E., Shubbar, E., Montelius, M., Ståhl, I., Swanpalmer, J., Nilsson, O., & Forssell-Aronsson, E. B. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225260 · Cited by 10
“where Frad and Fgem is the fractional response from monotherapy with radiation ( (177)Lu-octreotate or EBRT) and with gemcitabine, respectively [35].”
BackgroundTao, F., Cao, J.-F., Liu, Y., Chen, R.-Y., Shi, J., Li, C.-Y., Lu, J., Yang, G., & Chen, J. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741520 · Cited by 9
Environment-by-Environment Interactions Differ Across Genetic Backgrounds
Schmidlin, K., Ogbunugafor, C. B., Sastokas, A., & Geiler‐Samerotte, K. (2025) · Molecular Biology and Evolution · doi:10.1093/molbev/msaf287 · Cited by 10
“These models include the additive, average, Bliss, and highest single agent models (Bliss 1939; Yeh et al. 2009; Foucquier and Guedj 2015; Madani Tonekaboni et al. 2018; Meyer et al. 2020).”
InfluentialShao, F., Li, H., Hsieh, K., Zhang, P., Li, S., & Wang, T. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.027 · Cited by 10
“…the practice for other diseases, there is a critical need to screen combinations using various antibiotic candidates and determine whether the combined effect is greater than or less than the expected effects from the individual antibiotics, classified as synergism and antagonism, respectively 31 .”
BackgroundTP53-dependence on the effect of doxorubicin and Src inhibitor combination therapy
Lee, Y. S., Choi, J.-Y., Lee, J., Shim, D. M., Kim, J., Park, W., Nam, D.-H., & Seo, S. W. (2018) · Tumor Biology · doi:10.1177/1010428318794217 · Cited by 10
Microbubble‐Controlled Delivery of Biofilm‐Targeting Nanoparticles to Treat MRSA Infection
Chung, J. Y., Ahn, Y., Lee, J. H., Yang, S., Lee, S. C., Kong, H., & Chung, H. J. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202508291 · Cited by 11
Identification of Robust Antibiotic Subgroups by Integrating Multi-Species Drug–Drug Interactions
Lv, J. Z., Liu, G., Ju, Y., Huang, H., Li, D., & Sun, Y. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00937 · Cited by 8
Nashebi, R., Sarı, M., & Kotil, S. (2024) · PeerJ · doi:10.7717/peerj.16917 · Cited by 10
“…studies have demonstrated that the use of antagonistically interacting antibiotics in treating wildtype bacteria results in a slower development of resistance compared to synergistic antibiotics ( Hegreness et al., 2008 ; Chait, Craney & Kishony, 2007 ; Yeh et al., 2009 ; Torella et al., 2010 ).”
BackgroundLiang, X., Liu, Z., Wang, Y., Zhang, Y., Deng, W., Liu, Q., Lu, Z., Li, K., Chang, Y., & Wei, L. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1470891 · Cited by 9
Teixeira‐Santos, R., Rocha, R., Moreira-Rosário, A., Monteiro‐Soares, M., Cantón, R., Rodrigues, A. G., & Pina‐Vaz, C. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00610-12 · Cited by 9
“5 MIC of each drug was chosen since the breakpoints to AND and FLU are being reviewed and their values are species dependent (20, 22), because a new CLSI protocol is not already available, and because antagonistic and synergistic classifications usually rely on deviations from additivity (36).”
Background(Non-)translational medicine: targeting bacterial RNA
Dinan, A. M., & Loftus, B. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00230 · Cited by 7
Casal, D., Iria, I., Ramalho, J. S., Alves, S., Mota‐Silva, E., Mascarenhas‐Lemos, L., Pontinha, C. M. M., Cabral, M. G., Ferreira-Silva, J., Ferraz-Oliveira, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44153-y · Cited by 7
Liu, H., Cui, G., Ma, D., Zhang, Y., & Xue, F. (2021) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2021.1920581 · Cited by 7
Lozano-Huntelman, N. A., Bullivant, A., Chacon-Barahona, J. A., Valencia, A., Ida, N., Zhou, A., Kalhori, P., Bello, G., Xue, C., Boyd, S. M., et al. (2023) · Evolutionary Applications · doi:10.1111/eva.13608 · Cited by 8
“…the past 15 years, there has been substantial progress in determining and analyzing higher-order interactions (Beppler et al., 2016, 2017; Cokol et al., 2017; Lozano-Huntelman et al., 2021; Palmer et al., 2015; Tekin et al., 2016; Tekin, White, et al., 2018 ; Yeh et al., 2009; Zimmer et al., 2016).”
BackgroundSelf-citationAzimi, L., & Lari, A. R. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.09.049 · Cited by 6
Sandblom, V., Spetz, J. K. E., Shubbar, E., Montelius, M., Ståhl, I., Swanpalmer, J., Nilsson, O., & Forssell-Aronsson, E. B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233720 · Cited by 6
“where FEBRT and FTKI is the fractional response in an EBRT and a TKI monotherapy group at that time, respectively [22].”
BackgroundDynamics of a within-host drug resistance model with impulsive state feedback control
Jia, J., Zhao, Y., Zhao, Z., Liu, B., Song, X., & Hui, Y. (2022) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2023103 · Cited by 6
Ganguly, D., Santra, R. C., Mondal, T. K., & Das, S. K. (2016) · ChemistrySelect · doi:10.1002/slct.201500045 · Cited by 6
Ogbunugafor, C. B., & Eppstein, M. J. (2019) · IEEE Access · doi:10.1109/access.2019.2935911 · Cited by 9
“This is of particular importance in studies utilizing empirically determined fitness landscapes to understand the evolution of drug resistance, where the hope is to one day understand how the evolution of resistance occurs such that disease can be treated more effectively [20]–[23].”
BackgroundOrganization Principles in Genetic Interaction Networks
Jacobs, C. L., & Segrè, D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3567-9_3 · Cited by 6
TP53 alteration determines the combinational cytotoxic effect of doxorubicin and an antioxidant NAC
Lee, Y. S., Choi, Y. J., Lee, J., Shim, D. M., Park, W., & Seo, S. W. (2017) · Tumor Biology · doi:10.1177/1010428317700159 · Cited by 6
Optimal dynamic incentive scheduling for Hawk-Dove evolutionary games
Stuckey, K., Dua, R., Ma, Y., Parker, J., & Newton, P. K. (2022) · Physical review. E · doi:10.1103/physreve.105.014412 · Cited by 5
Modak, B., Rahman, M. S., Gazi, M. S., Uddin, M. A., & Rahman, T. (2015) · Stamford Journal of Microbiology · doi:10.3329/sjm.v3i1.22749 · Cited by 5
“prevalent and are a major health issue in current days (26-28).”
BackgroundEffect of pharmacodynamical interaction between nutlin-3a and aspirin in the activation of p53
Awan, M. S., Aslam, M., Liaquat, M., Bhatti, A. I., & Liaquat, A. (2021) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2021.110696 · Cited by 5
Kipnis, É., & Guery, B. P. (2010) · Antibiotiques · doi:10.1016/j.antib.2010.10.003 · Cited by 9
Response envelope analysis for quantitative evaluation of drug combinations
Du, D., Chang, C.-H., Wang, Y., Tong, P., Chan, W., Chiu, Y., Peng, B., Tan, L., Weinstein, J. N., & Lorenzi, P. L. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz091 · Cited by 6
A novel strategy to reduce overwintering inoculum of Monilinia laxa
Rungjindamai, N., Jeffries, P., & Xu, X. (2014) · European Journal of Plant Pathology · doi:10.1007/s10658-014-0473-y · Cited by 8
“Based on assumption of the Bliss independence (Xu et al. 2011; Yeh et al. 2009), the expected efficacy with both November and February sprays for a given product was calculated as EN+F= EN+[(1−EN)EF] (Table 1), where EN+F is the expected efficacy of the product with both November and February sprays, and EN and EF are…”
MethodLiang, Y., Zhao, H., Li, Y., Gao, F., Qiu, J., Liu, Z., & Li, Q. (2024) · Marine Environmental Research · doi:10.1016/j.marenvres.2024.106594 · Cited by 4
Khan, M. S. (2019) · Springer eBooks · doi:10.1007/978-981-13-9871-1_19 · Cited by 5
Antimicrobial activity of phenolic compounds isolated from Caesalpinia pulcherrimaPreprint
Khan, F., javed, S., Hanif, A., Faizi, S., Yousuf, M., & Kazmi, S. U. (2021) · Research Square · doi:10.21203/rs.3.rs-154525/v1 · Cited by 4
Min, Y.-H., Kim, Y., & Park, M. C. (2024) · Microorganisms · doi:10.3390/microorganisms12122515 · Cited by 3
Guerrero, R. F., Dorji, T., Harris, R. M., Shoulders, M. D., & Ogbunugafor, C. B. (2023) · eLife · doi:10.7554/elife.88480 · Cited by 3
“Generally, this study supports recent efforts that employ evolutionary perspectives to understand antimicrobial resistance ( Michel et al., 2008 ; Yeh et al., 2009 ; Rosenbloom et al., 2012 ; Baym et al., 2016 ; Beppler et al., 2016 ; Gjini and Wood, 2021 ; Ardell and Kryazhimskiy, 2021 ).”
BackgroundResultInfluentialModeling the mitotic regulatory network identifies highly efficient anti-cancer drug combinations
Wu, Y., Zhuo, X., Dai, Z., Guo, X., Wang, Y., Zhang, C., & Lai, L. (2014) · Molecular BioSystems · doi:10.1039/c4mb00610k · Cited by 4
Networking the Way towards Antimicrobial Combination Therapies
Jorge, P., Pereira, M. O., & Lourenço, A. M. G. (2014) · Advances in intelligent systems and computing · doi:10.1007/978-3-319-07581-5_24 · Cited by 5
“The annotation of this informat ism is becoming a hot topic due to its possible role on g resistance [5].”
BackgroundTranslational Modeling of Antibacterial Agents
Rao, G. G., Ly, N. S., Tsuji, B. T., Bulitta, J. B., & Forrest, A. (2016) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-44534-2_17 · Cited by 5
Deb, T., Ganguly, D., Sen, S., Giri, P., Dhar, P., & Das, S. K. (2018) · Journal of Chemical Sciences · doi:10.1007/s12039-018-1510-8 · Cited by 3
Seid, A., Berhane, N., Abayneh, T., & Tesfaye, S. (2021) · Microbes and Infectious Diseases /Microbes and Infectious Diseases · doi:10.21608/mid.2021.105562.1209 · Cited by 3
An efflux-susceptible antibiotic-adjuvant with systemic efficacy against mouse infections
Meir, O., Zaknoon, F., & Mor, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-21526-4 · Cited by 3
Pimenta, F., Abreu, A. C., Simões, L. C., & Simões, M. V. (2014) · Drug Resistance Updates · doi:10.1016/j.drup.2014.08.001 · Cited by 6
Mhlongo, L. C. (2018) · ResearchSpace (University of KwaZulu-Natal) · Cited by 3
Collateral Sensitivity to β-Lactam Antibiotics in Evolved Apramycin-Resistant MRSA
Wu, J., Wu, S., Liu, J., Li, C., Zheng, M., Li, F.-H., Zhang, Y., Wu, Y., & Yu, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212292 · Cited by 2
Resolving discrepancies between chimeric and multiplicative measures of higher-order epistasis
Chitra, U., Arnold, B., & Raphael, B. J. (2025) · Nature Communications · doi:10.1038/s41467-025-56986-5 · Cited by 4
Current Strategies for Addressing Antibiotic Resistance: A Comprehensive Review
Maji, R., Chowdhury, S., Kar, K., & Mazumder, K. (2025) · Journal of Bio-X Research · doi:10.34133/jbioxresearch.0040 · Cited by 7
The diverse effects of stress in cross-feeding systems
Hill, C. A., Lee, A. R., & Harcombe, W. R. (2026) · Current Opinion in Microbiology · doi:10.1016/j.mib.2026.102782 · Cited by 2
Extending the Lymphoblastoid Cell Line Model for Drug Combination Pharmacogenomics
Green, A. J., Anchang, B., Akhtari, F. S., Reif, D. M., & Motsinger‐Reif, A. A. (2021) · Pharmacogenomics · doi:10.2217/pgs-2020-0160 · Cited by 9
Zhang, H., Zhang, X., Huang, L., Fang, X., Khan, M. A., Xu, Y., An, J., Schooley, R. T., & Huang, Z. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101283 · Cited by 2
Farooq, A., Drotleff, B., Kroemer, N., Han, M., Li, J., Decousser, J., Schrey, D., Buyck, J. M., Grégoire, N., Nordmann, P., et al. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107457 · Cited by 2
Mixed Messages: How Bacteria Resolve Conflicting Signals
Young, J. W., & Elowitz, M. B. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.005 · Cited by 2
“By extending this analysis to additional drugs, we may be able to determine how universal this behavior is, how it depends on drug mechanism, and what role epistatic drug interactions (the effect of one drug on the relative efficacy of the other) play (Loewe, 1953; Yeh et al., 2009).”
BackgroundIrrgang, C., Eckmanns, T., von Kleist, M., Antão, E.-M., Ladewig, K., Wieler, L. H., & Körber, N. (2023) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-023-03707-2 · Cited by 3
“Dabei könnten gezielt solche Kombinationen identifiziert werden, die antimikrobielle Resistenzen verhindern [56, 57].”
BackgroundDobrova, A. O., Golovchenko, O., & Georgiyants, V. (2021) · Pharmacia · doi:10.3897/pharmacia.68.e39573 · Cited by 2
“It also happens frequently that patients are simultaneously taking several drugs (Mozayani and Raymon 2012; Yeh et al. 2009).”
BackgroundWhiteley, J. J., Greenstein, T., Moraes, M. P., Budak, M., Weiner, D. M., Abdi, A., Fleegle, J. D., Gómez, F. A., Via, L. E., Barry, C. E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.13.724664 · Cited by 2
Li, L., She, P., Liu, S., Li, Y., Li, Z., Yang, Y., Zhou, L., & Wu, Y. C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1078318 · Cited by 1
“Drug antagonism is emerging as a powerful tool to study underlying mechanisms of drug action (Yeh et al., 2009).”
BackgroundVirulence factor and microbial drug resistance
Chaturvedi, S., Rajak, S., & Sharma, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-31554-1.00016-9 · Cited by 1
UniSyn: a multi-modal framework with knowledge transfer for anti-cancer drug synergy prediction
Chen, Y., Zhang, Y., Niu, M., Wang, J., Ren, Z., Zou, Q., Song, J., & Luo, X. (2026) · Genome biology · doi:10.1186/s13059-026-03972-9 · Cited by 3
“This aligns with the parallel pathway inhibition theory [47], which suggests that drug synergy can arise when simultaneously targeting distinct pathways that regulate a common cellular function (Fig.”
Kushwaha, S. P., Sharma, P., & Kumar, S. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-4139-1.ch011 · Cited by 1
A mechanistic approach to optimize combination antibiotic therapy
Clarelli, F., Ankomah, P., Weiss, H., Conway, J. M., Forsdahl, G., & Wiesch, P. A. Z. (2024) · Biosystems · doi:10.1016/j.biosystems.2024.105385 · Cited by 1
Lozano-Huntelman, N. A., Cook, E., Bullivant, A., Ida, N., Zhou, A., Boyd, S. M., & Yeh, P. J. (2025) · Evolution · doi:10.1093/evolut/qpaf023 · Cited by 1
“…higher concentrations of antagonistic drugs are required to obtain the same degree of inhibition as that of synergistic drugs, antagonistic drugs can also be more effective in preventing the evolution of resistance (Chait et al., 2007; Hegreness et al., 2008; Michel et al., 2008; Yeh et al., 2009).”
Self-citationCombining forces to target bacteria
Refardt, D. (2012) · Evolutionary Applications · doi:10.1111/j.1752-4571.2012.00255.x · Cited by 2
“High-throughput screens have uncovered interactions between antibiotics and have lead to the surprising insight that, although certain combinations are less efficient, they may hinder the evolution of multidrug resistance in the long term (Yeh et al. 2009).”
BackgroundPharmacodynamic Issues in Antibiotic Combinations
Bulman, Z. P., Dillon, R. C., & Tsuji, B. T. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3323-5_4 · Cited by 1
Controlling Rogue Cells in Cancer and Bacterial Infections
Waldetoft, K. W., McDonald, J. F., & Brown, S. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804310-3.00021-1 · Cited by 1
Nazihahasma, H. S., Yusoff, A. A. M., Redzwan, N. M., Idris, Z., & Ahmad, F. (2021) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2021.110417 · Cited by 2
“Similarly, in the perspective of antimicrobials, antagonistic combinations can select antibiotic-resistant bacteria and minimize the evolution of resistance (Yeh et al., 2009).”
BackgroundSelective radiosensitization by nitazoxanide of quiescent clonogenic colon cancer tumour cells
Karlsson, H., Fryknäs, M., Senkowski, W., Larsson, R. L., & Nygren, P. (2022) · Oncology Letters · doi:10.3892/ol.2022.13243 · Cited by 3
“An expected combination SI or SF (SIe or SFe) was calculated as follows: SId x SIr=SIe (or SFd x SFr=SFe), in accordance with independent Bliss interaction (17).”
Screening combinatorial perturbations via a bifurcation-based method
Liu, L., Chen, Q., & Wang, R. (2022) · Modern Physics Letters B · doi:10.1142/s0217984922500178 · Cited by 1
Khan, Z. A., Hu, Y., Ghalandari, B., Ahmad, M., Abdullah, A., Jiang, L., & Ding, X. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116695 · Cited by 1
Transitions in interaction landscapes of multidrug combinationsPreprint
Kang, T. M., Østman, B., Cruz‐Loya, M., Lozano-Huntelman, N. A., Damoiseaux, R. D., Savage, V. M., & Yeh, P. J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/367664 · Cited by 1
“However, previous work indicates that antagonism may 60 be more beneficial for slowing down the rate of resistance evolution to the component drugs 61 [10, 14], because it creates more complex or rugged fitness landscapes.”
BackgroundSelf-citationA duplexed CRISPRi-based approach to predict synergistic antibiotic targets in Escherichia coliPreprint
Xiong, X., Furseth, H., McCoy, B., Slavic, L., Yuan, X. F., Chen, S., Baughn, A. D., Minato, Y., & Harcombe, W. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.15.594409 · Cited by 1
Design of two-stage multidrug chemotherapy schedules using replicator game dynamicsPreprint
Stuckey, K., & Newton, P. K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.16.603768 · Cited by 1
Global Biogeography and Local Adaptation of Streptomyces
Schlatter, D. (2013) · University of Minnesota Digital Conservancy (University of Minnesota)
An exploration of the dynamics of selection for resistance to herbicides
Lynch, J. M. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33686926 · Cited by 1
Using Chemical Structure as Probes for Biological Networks
Nigsch, F. (2011) · Wiley eBooks · doi:10.1002/9781118131411.ch9
Downing, T. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2716
“This example indicates that antagonistic epistasis between beneficial variants will slow the emergence of multidrug resistance in pathogens, but that synergistic effects will accelerate this process (see Ref”
BackgroundMcClure, N. S. (2013) · QSpace (Queen's University Library)
Predicting Drug Synergy and Antagonism from Genetic Interaction NeighborhoodsPreprint
Young, J. H., & Marcotte, E. M. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/050567
Immune Checkpoint Blockade: Subjugation of the Masses
Lussier, D. M., Appel, N., Johnson, J. L., & Blattman, J. N. (2017) · InTech eBooks · doi:10.5772/67687
“Another opportunity in designing combinatorial treatments from an evolutionarily informed perspective is that of shaping selection pressures so as to make resistant cells least fit by using antagonistic drug interactions [56].”
BackgroundBackward evolution from gene network dynamicsPreprint
Belete, M. K., Charlebois, D. A., & Balázsi, G. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/369371
“To investigate the dynamics of a single mutation on population fitness, we assume the total mutant single-cell fitness in a stressful environment is due to the effect of both regulator and effector protein levels (Nevozhay et al, 2012; Yeh et al, 2009).”
BackgroundShekhar‐Guturja, T. (2016) · TSpace (University of Toronto)
Hill, J. A. (2014) · TSpace (University of Toronto)
Atividade antimicrobiana e citotoxicidade de emulsões de quitosana/gelatina/óleo de copaíba
Marangon, C. A. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.82.2017.tde-03102017-152846
Metadata
- Authors
- Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R.
- Affiliations
- Harvard University (US)
- Broad Institute (US)
- Corresponding author
- Kishony, Roy
- Venue
- Nature Reviews Microbiology
- Published
- 2009-06
- Volume
- 7
- Issue
- 6
- Pages
- 460-466
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC2855488
- OpenAlex
- W2115076532
- Cited by
- 350
- References
- 68
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 23 · 2023: 29 · 2022: 22 · 2021: 27 · 2020: 14 · 2019: 23 · 2018: 22 · 2017: 29 · 2016: 23 · 2015: 16 · 2014: 31 · 2013: 20 · 2012: 13
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation
- National Institutes of Health
- National Defense Science and Engineering Graduate
- National Institute of General Medical Sciences (R01GM081617)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- drug interactions, antibiotic resistance, drug antagonism, drug synergy, systems biology, mechanisms of drug action, resistance evolution
- MeSH terms
- Drug Antagonism, Drug Interactions, Drug Resistance, Microbial, Drug Synergism, Models, Theoretical, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.